Exploring the Efficacy and Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Androgenic Alopecia

The study investigated the efficacy of mesenchymal stem cell-derived exosomes for treating androgenic alopecia in 85 patients aged 18-55. Over 12 weeks, the treatment group experienced a significant increase in hair density, with a mean rise of 35 hairs/cm² from a baseline of 100 hairs/cm², compared to a negligible increase of 3 hairs/cm² in the placebo group. The results, with a p-value of 0.001, suggest that mesenchymal stem cell-derived exosomes significantly enhance hair density and thickness, presenting a promising treatment option for androgenic alopecia.